首页> 美国卫生研究院文献>other >Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells
【2h】

Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells

机译:二氢吡啶类化合物在白血病HL-60细胞中抑制钙离子进入

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A series of 1,4-dihydropyridines (DHPs) were investigated as inhibitors of capacitative calcium influx through store-operated calcium (SOC) channels. Such channels activate after ATP-elicited release of inositol trisphosphate (IP3)-sensitive calcium stores in leukemia HL-60 cells. The most potent DHPs were those containing a 4-phenyl group with an electron-withdrawing substituent, such as m- or p-nitro- or m-trifluoromethyl (IC50 values: 3–6 μM). Benzyl esters, corresponding to the usual ethyl/methyl esters of the DHPs developed as L-type calcium channel blockers, retained potency at SOC channels, as did N-substituted DHPs. N-Methylation reduced by orders of magnitude the potency at L-type channels resulting in DHPs nearly equipotent at SOC and L-type channels. DHPs with N-ethyl, N-allyl, and N-propargyl groups also had similar potencies at SOC and L-type channels. Replacement of the usual 6-methyl group of DHPs with larger groups, such as cyclobutyl or phenyl, eliminated activity at the SOC channels; such DHPs instead elicited formation of inositol phosphates and release of IP3-sensitive calcium stores. Other DHPs also caused a release of calcium stores, but usually at significantly higher concentrations than those required for the inhibition of capacitative calcium influx. Certain DHPs appeared to cause an incomplete blockade of SOC channel-dependent elevations of calcium, suggesting the presence of more than one class of such channels in HL-60 cells. N-Methylnitrendipine (IC50 2.6 μM, MRS 1844) and N-propargylnifrendipine (IC50 1.7 μM, MRS 1845) represent possible lead compounds for the development of selective SOC channel inhibitors.
机译:研究了一系列的1,4-二氢吡啶(DHP)作为通过存储操作钙(SOC)通道的电容性钙流入抑制剂。 ATP诱导白血病HL-60细胞中的三磷酸肌醇(IP3)敏感性钙存储释放后,此类通道激活。最有效的DHP是含有4-苯基和吸电子取代基的DHP,例如间硝基或对硝基硝基或间三氟甲基(IC50值:3–6μM)。与开发为L型钙通道阻滞剂的DHP的常用乙基/甲基酯相对应的苄酯,与N-取代的DHP一样,在SOC通道上保留了效力。 N甲基化使L型通道的效能降低了几个数量级,导致DHP在SOC和L型通道上几乎相等。具有N-乙基,N-烯丙基和N-炔丙基的DHP在SOC和L型通道上也具有相似的效价。用较大的基团(例如环丁基或苯基)取代通常的DHP的6-甲基,消除了SOC通道的活性;此类DHP引发了肌醇磷酸酯的形成并释放了IP3敏感的钙库。其他DHP也会引起钙存储的释放,但是通常比抑制电容性钙流入所需的浓度高得多。某些DHP似乎导致不完全阻断SOC通道依赖性钙的升高,表明HL-60细胞中存在多于一类的此类通道。 N-甲基硝苯地平(IC50 2.6μM,MRS 1844)和N-炔丙基尼夫地平(IC50 1.7μM,MRS 1845)代表了开发选择性SOC通道抑制剂的可能先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号